In a report released today, Suraj Kalia from Northland Securities maintained a Buy rating on Titan Medical Inc (TMDI), with a price target of $6. The company’s shares opened today at $2.60.
According to TipRanks.com, Kalia is a 5-star analyst with an average return of 11.0% and a 60.1% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Varex Imaging Corporation, and Strata Skin Sciences Inc.
Currently, the analyst consensus on Titan Medical Inc is a Moderate Buy with an average price target of $5.
See today’s analyst top recommended stocks >>
The company has a one-year high of $7.75 and a one-year low of $0.19. Currently, Titan Medical Inc has an average volume of 309.2K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Titan Medical, Inc. engages in the designing, development, and commercialization of new robotic surgical technologies. It focuses on developing Sport Surgical System, which is a single incision robotic surgical system that features multi-articulated instruments with single-use replaceable tips, and 3D display.
